Aurinia replaced manual adverse event intake with Qinecsa's Reportum after launching LUPKYNIS.

Aurinia needed modern pharmacovigilance infrastructure as serious adverse event volumes were expected to rise. It implemented Reportum in June 2021 for multi-channel intake from consumers, clinicians and specialty pharmacies. The page reports up to 70% less safety team workload, no manual reconciliation or database entry, and a strong return on investment.

Qinecsa is a pharmacovigilance technology and services company, used by pharma to automate adverse event intake and run signal detection and safety operations

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.